Evidence map›Paper›PMID 31419268›Full record

ArticlePloS one2019

Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.

Guillaume Binson, Claire Grignon, Gwenaël Le Moal, Pauline Lazaro, Jérémy Lelong, France Roblot, Nicolas Venisse, Antoine Dupuis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guillaume BinsonDepartment of Pharmacy, University Hospital of Poitiers, Poitiers, France.ORCID 0000-0002-0465-7451
Claire GrignonDepartment of Pharmacy, University Hospital of Poitiers, Poitiers, France.
Gwenaël Le MoalDepartment of Infectious Diseases, University Hospital of Poitiers, Poitiers, France.
Pauline LazaroDepartment of Pharmacy, University Hospital of Poitiers, Poitiers, France.
Jérémy LelongDepartment of Pharmacokinetics, University Hospital of Poitiers, Poitiers, France.
France RoblotDepartment of Infectious Diseases, University Hospital of Poitiers, Poitiers, France.
Nicolas VenisseCIC Inserm, Poitiers, France.
Antoine DupuisDepartment of Pharmacy, University Hospital of Poitiers, Poitiers, France.ORCID 0000-0003-2471-5679
Université de Poitiers · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While treatment of serious infectious diseases may require high-dose amoxicillin, continuous infusion may be limited by lack of knowledge regarding the chemical stability of the drug. Therefore, we have performed a comprehensive study so as to determine the chemical stability of high-dose amoxicillin solutions conducive to safe and effective continuous intravenous administration using portable elastomeric pumps. First, amoxicillin solubility in water was assessed within the range of 25 to 300 mg/mL. Then, amoxicillin solutions were prepared at different concentrations (25, 50, 125, 250 mg/mL) and stored in different conditions (5±2°C, 25±1°C, 30±1°C and 37±1°C) to investigate the influence of concentration and temperature on the chemical stability of amoxicillin. Finally, its stability was assessed under optimized conditions using a fully validated HPLC-UV stability-indicating method. Degradation products of amoxicillin were investigated by accurate mass determination using high-resolution mass spectrometry. Amoxicillin displayed limited water solubility requiring reconstitution at concentrations below or equal to 150 mg/mL. Amoxicillin degradation were time, temperature as well as concentration-dependent, resulting in short-term stability, in particular at high concentrations. Four degradation products of amoxicillin have been identified. Among them, amoxicilloic acid and diketopiperazine amoxicillin are at risk of allergic reaction and may accumulate in the patient. Optimized conditions allowing for continuous infusion of high-dose amoxicillin has been determined: amoxicillin should be reconstituted at 25 mg/mL and stored up to 12 hours at room temperature (22 ± 4°C) or up to 24 hours between 4 and 8°C.

Indexed as

Drug StabilityElastomersInfusion PumpsAmoxicillinAnti-Bacterial AgentsBacterial InfectionsChemistry, PharmaceuticalDose-Response Relationship, DrugHumansInfusions, IntravenousSolubilityTemperatureTime FactorsAmoxicillinAnti-Bacterial AgentsElastomers

Identifiers

PMID31419268
PMCPMC6697341
OpenAlexW2968122707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.